Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets

Stock Information for Codexis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Codexis Inc.

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
Codexis Announces New Employment Inducement Grants
Codexis to Report Third Quarter 2024 Financial Results on October 31
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
Codexis Announces New Employment Inducement Grants
Codexis to Participate in Upcoming Healthcare Conferences

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.